Optimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)–Positive Non–Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors

The treatment of advanced non–small-cell lung cancer (NSCLC) has undergone a paradigm shift in the last decade. Molecular characterization of the disease has led to the rapid development of personalized medicine and swift delivery of targeted therapies to patients. The discovery of the anaplastic ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Abhay, Chen, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425086/
https://www.ncbi.nlm.nih.gov/pubmed/32821158
http://dx.doi.org/10.2147/CMAR.S260274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425086/
https://www.ncbi.nlm.nih.gov/pubmed/32821158
http://dx.doi.org/10.2147/CMAR.S260274

Ejemplares similares